�� 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. Migrastatin and isomigrastatin analogues have been synthesised in order to contribute to structure-activity studies on tumour cell migration inhibitors. These include macrocycles varying in ring size, functionality and alkene stereochemistry, as well as glucuronides. The synthesis work included application of the Saegusa-Ito reaction for regio- and stereoselective unsaturated macroketone formation, diastereoselective Brown allylation to generate 9-methylmigrastatin analogues and chelation-induced anomerisation to vary glucuronide configuration. Compounds were tested in vitro against both breast and pancreatic cancer cell lines and inhibition of tumour cell migration was observed in both ...
Natural products have been perceived as privileged structures in drug discovery based on their evol...
Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a di...
Natural products have been perceived as privileged structures in drug discovery based on their evolu...
Migrastatin and isomigrastatin analogues have been synthesised in order to contribute to structure-a...
Journal articleMigrastatin and isomigrastatin analogues have been synthesised in order to contribute...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
An efficient and scalable synthesis of a key acyclic intermediate used for the preparation of migras...
Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a di...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
A macrolactona da migrastatina 10 é um composto que apresenta alta atividade de inibição de migração...
Migrastatin is a secondary metabolite that is formed from the bacterium Streptomyces platensis. This...
An efficient and scalable synthesis of a key acyclic intermediate used for the preparation of migras...
Migrastatin is a secondary metabolite that is formed from the bacterium Streptomyces platensis. This...
Natural products have been perceived as privileged structures in drug discovery based on their evol...
Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a di...
Natural products have been perceived as privileged structures in drug discovery based on their evolu...
Migrastatin and isomigrastatin analogues have been synthesised in order to contribute to structure-a...
Journal articleMigrastatin and isomigrastatin analogues have been synthesised in order to contribute...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
An efficient and scalable synthesis of a key acyclic intermediate used for the preparation of migras...
Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a di...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
The synthesis of the macrolactone core of migrastatin 2, its potent anti-metastasis analogue 34, and...
A macrolactona da migrastatina 10 é um composto que apresenta alta atividade de inibição de migração...
Migrastatin is a secondary metabolite that is formed from the bacterium Streptomyces platensis. This...
An efficient and scalable synthesis of a key acyclic intermediate used for the preparation of migras...
Migrastatin is a secondary metabolite that is formed from the bacterium Streptomyces platensis. This...
Natural products have been perceived as privileged structures in drug discovery based on their evol...
Tumor metastasis is a complex process in which cells detach from the primary tumor and colonize a di...
Natural products have been perceived as privileged structures in drug discovery based on their evolu...